Runcaciguat is a soluble guanylate cyclase activator developed by Bayer for non-proliferative diabetic retinopathy and chronic kidney disease.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.